| |
|
|
|
Celldex Therapeutics Inc.  
|
|
4.94 -0.2 (-0.04%) |
03-22 16:00 |
|
Open: |
5.13 |
Pre close: |
5.14 |
Target:
|
6.60
|
|
High: |
5.21 |
Low: |
4.85 |
Resistance:
|
5.65
6.43
|
|
Volume: |
382,765 |
Market Cap: |
61M |
Support:
|
4.38
3.64
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.87
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
5.04  |
Signal(12,26,9): |
-0.21 |
|
MA(100): |
4.86 |
Stochastic Oscillator |
%K(14,3):
|
50.66 |
|
MA(250): |
8.17 |
%D(3): |
39.20 |
|
Average Volume(K) |
3-Month: |
39461
|
52-Week |
High:
|
37.20 |
|
10-Days: |
28968 |
Low: |
2.70 |
|
RSI |
RSI(14):
|
46.98 |
Change(%): |
-86.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-6.650 |
Return on Equity (ttm) |
-83.9 |
Shares Out. (M) |
12.44 |
|
EPS Est. Current Year |
-1.040 |
Return on Assets (ttm) |
-64.1 |
Shares Float (M) |
5.78 |
|
EPS Est. Next Year |
-0.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.60 |
|
EPS Est. Next Quarter |
-0.280 |
Qtrly Rev. Growth |
-49.0 |
% Held by Institutions |
37.00 |
|
Forward EPS |
-0.818 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.480 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.74 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.29 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-75.23 |
P/S |
67531424.00 |
|
Operating Margin |
-790.56 |
Levered Free Cash Flow
(M) |
-50.92 |
P/CF |
-0.82 |
|
|
|
|
|
|
